Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-culture of autologous chondrocytes and mesenchymal stem cells for cartilage formation
NL-OMON31506Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Feb 2009
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of mesenchymal stem cells in cartilage defect and osteoarthritis (OA), sponsored by University Medical Center Utrecht. Primary endpoints: Optimal cell ratio for cartilage formation after 6 weeks, Alcian blue staining and 4 more. Started Feb 2009; status: active, not recruiting.
02
Drugs
mesenchymal stem cells
03
Conditions
cartilage defectosteoarthritis (OA)
Beyond the preview
Go deeper on NL-OMON31506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31506.